TARA News and Press, ArTara Therapeutics Inc. From 03/09/22

ArTara Therapeutics press release (NASDAQ:TARA): Q4 GAAP EPS of -$0.91 beats by $0.03. As of December 31, 2021, cash, cash equivalents and marketable debt securities totaled $130.7 million. For further details see: ArTara Therapeutics GAAP EPS of -$0.91 beats by $0.03

- Phase 1 Study of TARA-002 in Patients with Non-Muscle Invasive Bladder Cancer Under Way - - Strong Cash Position of $130.7M as of December 31, 2021 Expected to Fund Operations into Mid-2024 - NEW YORK, March 09, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (N...

NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in fireside chats at two upcoming virtual...

NEW YORK, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a virtual fireside chat at the Guggenhe...

NEW YORK, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Jathin Bandari, M.D., as Chief Medical Officer. Dr. Bandari i...

NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that management will present at the H.C. Wainw...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Protara Therapeutics, Inc. Announces FDA Clearance of Investigational New Drug Application for TARA-002” “The Buzz” Show: Protara Therapeutics, Inc. ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Freyr Battery (NYSE: FREY ) stock is on the move Tuesday and there’s a couple of recent pieces of news behind its rise. Source: Shutterstock The first big bit of news today is Credit Suisse analyst Mahe...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Protara Therapeutics (NASDAQ: TARA ) stock is heading higher on Tuesday following some major news from the U.S. Food and Drug Administration (FDA). Source: CI Photos / Shutterstock.com Let’s dive into t...

R. R. Donnelley & Sons (NYSE:RRD) +31%. Inhibrx (NASDAQ:INBX) +17% on favorable safety profile in patients with alpha-1 antitrypsin deficiency and demonstrates the potential to achieve normal alpha-1 antitrypsin levels with monthly dosing. Protara Therapeutics (NASDAQ:TARA) +26%...